Skip to content
★ Sign in to follow
GL

Gert L. Perlhagen

Executive
Novocure Ltd
Total declarations
14
Company
1
▲ Purchases (1 ops.)
€813k
▼ Sales (8 ops.)
€1.1M

Latest filing published 16 Mar 2017 for Novocure Ltd, €813k.

Filing timeline

BuySale
Gert L. Perlhagen

Insider track record

Disclosed buys
1
Disclosed sells
8
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 16 Mar 2017 · 3525 days ago · €813k
    +184.8%
    Entry US$7.55 · Close at T+365 US$21.50

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Gert L. Perlhagen: trading record in brief

Gert L. Perlhagen discloses dealings in Novocure Ltd to SEC (Form 4). The record holds 14 filings, for trades running from 7 October 2015 to 14 March 2017.

Market trades split into 1 purchase (€813k) and 8 sales (€1.1M). Netting one side against the other leaves €311k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant and 1 option exercise. So far in 2017, the count stands at 1 purchase and no sales.

The latest filing, published on 16 March 2017, reports an open-market purchase of €813k in Novocure Ltd. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Gert L. Perlhagen

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations13 total
  • ▲
    DirectorExecutivesNovocure Ltd
    866,250 USD14SEC
    125,000 shares@ US$6.9333.1% of flowOrdinary SharesSEC:0000899243-17-007750:0
    Canonical exit: 12 Jun 2017 (T+90)
  • ●
    DirectorExecutivesNovocure Ltd
    0SEC
    6,000,000 shares0Ordinary SharesSEC:0001123292-17-000594:0
  • ●
    DirectorExecutivesNovocure Ltd
    0SEC
    676,576 shares0Ordinary SharesSEC:0000899243-16-026439:0
  • ▼
    DirectorExecutivesNovocure Ltd
    200,200 USD12SEC
    110,000 shares@ US$1.827.3% of flowOrdinary SharesSEC:0000899243-16-026439:1
  • ▼
    DirectorExecutivesNovocure Ltd
    551,501 USD13SEC
    334,243 shares@ US$1.6520.2% of flowOrdinary SharesSEC:0000899243-16-026439:2
  • ▼
    DirectorExecutivesNovocure Ltd
    149,554 USD12SEC
    69,560 shares@ US$2.155.5% of flowOrdinary SharesSEC:0000899243-16-026439:3
  • ▼
    DirectorExecutivesNovocure Ltd
    36,489 USD11SEC
    16,893 shares@ US$2.161.3% of flowOrdinary SharesSEC:0000899243-16-026439:4
  • ▼
    DirectorExecutivesNovocure Ltd
    113,761 USD11SEC
    52,667 shares@ US$2.164.2% of flowOrdinary SharesSEC:0000899243-16-026439:5
  • ▼
    DirectorExecutivesNovocure Ltd
    12,476 USD11SEC
    5,913 shares@ US$2.110.5% of flowOrdinary SharesSEC:0000899243-16-026439:7
  • ▼
    DirectorExecutivesNovocure Ltd
    38,496 USD11SEC
    17,740 shares@ US$2.171.4% of flowOrdinary SharesSEC:0000899243-16-026439:8
  • ◇
    DirectorExecutivesNovocure Ltd
    744,516 USD14SEC
    207,386 shares@ US$3.5926.6% of flowOrdinary SharesSEC:0000899243-16-019617:0
  • ●
    DirectorExecutivesNovocure Ltd
    0SEC
    5,755,705 sharesOrdinary SharesSEC:0000899243-15-006576:0
  • ◆
    DirectorExecutivesNovocure Ltd
    547,288 USD0SEC
    154,601 shares@ US$3.54Ordinary SharesSEC:0000899243-15-006576:1

13 of 13 declarations